| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,862 |
9,435 |
$54K |
| 93000 |
|
4,015 |
4,011 |
$45K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,152 |
1,078 |
$16K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,627 |
1,627 |
$15K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,045 |
1,041 |
$10K |
| 90686 |
|
708 |
708 |
$7K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
269 |
269 |
$2K |
| 90658 |
|
318 |
318 |
$905.75 |
| 3074F |
|
2,580 |
2,540 |
$875.00 |
| 3079F |
|
969 |
957 |
$752.50 |
| 99397 |
|
297 |
297 |
$726.65 |
| 3078F |
|
2,365 |
2,334 |
$672.50 |
| 3075F |
|
642 |
637 |
$447.50 |
| 36415 |
Collection of venous blood by venipuncture |
6,942 |
6,910 |
$223.69 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
117 |
117 |
$203.57 |
| G0008 |
Administration of influenza virus vaccine |
203 |
203 |
$124.19 |
| Q2036 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) |
50 |
50 |
$58.34 |
| 1160F |
|
3,633 |
3,570 |
$40.00 |
| 3077F |
|
114 |
114 |
$35.00 |
| 1125F |
|
1,076 |
1,069 |
$25.00 |
| G9507 |
Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs) |
711 |
698 |
$0.00 |
| 0521F |
|
885 |
879 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
3,890 |
3,726 |
$0.00 |
| 1159F |
|
3,082 |
3,031 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
302 |
302 |
$0.00 |
| 3288F |
|
200 |
193 |
$0.00 |
| 4120F |
|
153 |
152 |
$0.00 |
| 4013F |
|
1,358 |
1,345 |
$0.00 |
| 3725F |
|
372 |
369 |
$0.00 |
| 3051F |
|
51 |
50 |
$0.00 |
| 3046F |
|
42 |
41 |
$0.00 |
| 3050F |
|
24 |
24 |
$0.00 |
| 4025F |
|
12 |
12 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
27 |
27 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
13 |
13 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
13 |
12 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
729 |
715 |
$0.00 |
| 1000F |
|
916 |
913 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
4,607 |
4,431 |
$0.00 |
| 3044F |
|
458 |
455 |
$0.00 |
| 4016F |
|
576 |
572 |
$0.00 |
| 1036F |
|
731 |
730 |
$0.00 |
| 3008F |
|
8,401 |
8,082 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
222 |
222 |
$0.00 |
| 4015F |
|
484 |
477 |
$0.00 |
| 3048F |
|
125 |
123 |
$0.00 |
| G8432 |
Depression screening not documented, reason not given |
429 |
426 |
$0.00 |
| H0001 |
Alcohol and/or drug assessment |
74 |
74 |
$0.00 |
| G8473 |
Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed |
75 |
75 |
$0.00 |
| 3049F |
|
53 |
52 |
$0.00 |
| 3351F |
|
132 |
132 |
$0.00 |
| 3080F |
|
52 |
52 |
$0.00 |
| 3014F |
|
12 |
12 |
$0.00 |
| 99429 |
|
216 |
206 |
$0.00 |
| 4010F |
|
48 |
48 |
$0.00 |
| 99386 |
|
24 |
24 |
$0.00 |